WO2005058317A1 - Inhibiteurs du transporteur-1 de la glycine - Google Patents
Inhibiteurs du transporteur-1 de la glycine Download PDFInfo
- Publication number
- WO2005058317A1 WO2005058317A1 PCT/EP2004/014472 EP2004014472W WO2005058317A1 WO 2005058317 A1 WO2005058317 A1 WO 2005058317A1 EP 2004014472 W EP2004014472 W EP 2004014472W WO 2005058317 A1 WO2005058317 A1 WO 2005058317A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- optionally substituted
- alkyl
- compound
- phenyl
- 4alkyl
- Prior art date
Links
- 0 *c(c(*)c(c(*)c1*)[N+]([O-])=O)c1N1CCOCC1 Chemical compound *c(c(*)c(c(*)c1*)[N+]([O-])=O)c1N1CCOCC1 0.000 description 1
- VSKJABBRYHPQLH-UHFFFAOYSA-N CCc(cc1)ccc1C(N(C(CC1)C2)C1CC2C(Nc(cc1)cc(F)c1N1CCOCC1)=O)=O Chemical compound CCc(cc1)ccc1C(N(C(CC1)C2)C1CC2C(Nc(cc1)cc(F)c1N1CCOCC1)=O)=O VSKJABBRYHPQLH-UHFFFAOYSA-N 0.000 description 1
- POHRVSFQBGWXFO-UHFFFAOYSA-N CCc1ccc(CN2C3CC(CNc(cc4)cc(F)c4N4CCOCC4)CC2CC3)cc1 Chemical compound CCc1ccc(CN2C3CC(CNc(cc4)cc(F)c4N4CCOCC4)CC2CC3)cc1 POHRVSFQBGWXFO-UHFFFAOYSA-N 0.000 description 1
- VRDIXMJMNODFAC-UHFFFAOYSA-N COC=C1CC(CC2)N(Cc3ccc(C(F)(F)F)cc3)C2C1 Chemical compound COC=C1CC(CC2)N(Cc3ccc(C(F)(F)F)cc3)C2C1 VRDIXMJMNODFAC-UHFFFAOYSA-N 0.000 description 1
- VORHUJPCHSFCSH-UHFFFAOYSA-N O=C(NC1CCCC1)N(CC1CC(CC2)NC2C1)c(cc1)cc(F)c1N1CCOCC1 Chemical compound O=C(NC1CCCC1)N(CC1CC(CC2)NC2C1)c(cc1)cc(F)c1N1CCOCC1 VORHUJPCHSFCSH-UHFFFAOYSA-N 0.000 description 1
- ICEHJQPVQIIUPX-UHFFFAOYSA-N O=C1CC(CC2)N(Cc3ccc(C(F)(F)F)cc3)C2C1 Chemical compound O=C1CC(CC2)N(Cc3ccc(C(F)(F)F)cc3)C2C1 ICEHJQPVQIIUPX-UHFFFAOYSA-N 0.000 description 1
- NVEUPNHKAYRTFZ-UHFFFAOYSA-N O=CC1CC(CC2)N(Cc3ccc(C(F)(F)F)cc3)C2C1 Chemical compound O=CC1CC(CC2)N(Cc3ccc(C(F)(F)F)cc3)C2C1 NVEUPNHKAYRTFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0329360A GB0329360D0 (en) | 2003-12-18 | 2003-12-18 | Compounds |
GB0329360.2 | 2003-12-18 | ||
GB0413107A GB0413107D0 (en) | 2004-06-11 | 2004-06-11 | Compounds |
GB0413107.4 | 2004-06-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005058317A1 true WO2005058317A1 (fr) | 2005-06-30 |
Family
ID=34702517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/014472 WO2005058317A1 (fr) | 2003-12-18 | 2004-12-16 | Inhibiteurs du transporteur-1 de la glycine |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005058317A1 (fr) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006066121A2 (fr) * | 2004-12-16 | 2006-06-22 | Janssen Pharmaceutica N.V. | Combinaison d'un inhibiteur de transporteur glycine (glyt1) et d'un antipsychotique destinee au traitement de symptomes de la schizophrenie ainsi que la preparation et l'utilisation de ce compose |
EP1871165A2 (fr) * | 2005-04-11 | 2008-01-02 | Yale University Corporation | Methode de traitement d'un prodrome schizophrenique |
FR2941954A1 (fr) * | 2009-02-10 | 2010-08-13 | Sanofi Aventis | Derives de n-°(6-aza-bicyclo°3.2.1!oct-1-yl)-aryl-methyl! benzamide, leur preparation et leur application en therapeutique |
FR2941953A1 (fr) * | 2009-02-10 | 2010-08-13 | Sanofi Aventis | Derives de n-°(2-aza-bicyclo°2.1.1!hex-1-yl)-benzamide, leur preparation et leur application en therapeutique |
US8420670B2 (en) | 2007-08-22 | 2013-04-16 | Abbott Laboratories | 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
US8563617B2 (en) | 2009-02-16 | 2013-10-22 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8642587B2 (en) | 2009-02-16 | 2014-02-04 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy |
US8653100B2 (en) | 2008-04-01 | 2014-02-18 | Abbvie Inc. | Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8846741B2 (en) | 2011-11-18 | 2014-09-30 | Abbvie Inc. | N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
WO2014154488A1 (fr) | 2013-03-28 | 2014-10-02 | Syngenta Participations Ag | Procédés de lutte contre des organismes nuisibles résistant aux néonicotinoïdes |
US8853196B2 (en) | 2011-08-05 | 2014-10-07 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9045459B2 (en) | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9309200B2 (en) | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9550754B2 (en) | 2014-09-11 | 2017-01-24 | AbbVie Deutschland GmbH & Co. KG | 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9586945B2 (en) | 2013-10-17 | 2017-03-07 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9586942B2 (en) | 2013-10-17 | 2017-03-07 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999045011A1 (fr) * | 1998-03-06 | 1999-09-10 | Janssen Pharmaceutica N.V. | Inhibiteurs du transport de la glycine |
WO2003053942A1 (fr) * | 2001-12-20 | 2003-07-03 | H. Lundbeck A/S | Derives d'aryloxyphenyle et d'arylsulfanylphenyle |
-
2004
- 2004-12-16 WO PCT/EP2004/014472 patent/WO2005058317A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999045011A1 (fr) * | 1998-03-06 | 1999-09-10 | Janssen Pharmaceutica N.V. | Inhibiteurs du transport de la glycine |
WO2003053942A1 (fr) * | 2001-12-20 | 2003-07-03 | H. Lundbeck A/S | Derives d'aryloxyphenyle et d'arylsulfanylphenyle |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006066121A3 (fr) * | 2004-12-16 | 2006-08-10 | Janssen Pharmaceutica Nv | Combinaison d'un inhibiteur de transporteur glycine (glyt1) et d'un antipsychotique destinee au traitement de symptomes de la schizophrenie ainsi que la preparation et l'utilisation de ce compose |
WO2006066121A2 (fr) * | 2004-12-16 | 2006-06-22 | Janssen Pharmaceutica N.V. | Combinaison d'un inhibiteur de transporteur glycine (glyt1) et d'un antipsychotique destinee au traitement de symptomes de la schizophrenie ainsi que la preparation et l'utilisation de ce compose |
EP1871165A2 (fr) * | 2005-04-11 | 2008-01-02 | Yale University Corporation | Methode de traitement d'un prodrome schizophrenique |
EP1871165A4 (fr) * | 2005-04-11 | 2009-10-21 | Yale University Corp | Methode de traitement d'un prodrome schizophrenique |
US8492418B2 (en) | 2005-04-11 | 2013-07-23 | Yale University | Method of treating schizophrenia prodrome |
US8420670B2 (en) | 2007-08-22 | 2013-04-16 | Abbott Laboratories | 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
US8653100B2 (en) | 2008-04-01 | 2014-02-18 | Abbvie Inc. | Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
US8957089B2 (en) | 2008-04-01 | 2015-02-17 | AbbVie Deutschland GmbH & Co. KG | Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
WO2010092286A1 (fr) * | 2009-02-10 | 2010-08-19 | Sanofi-Aventis | Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique |
WO2010092287A1 (fr) * | 2009-02-10 | 2010-08-19 | Sanofi-Aventis | Derives de n-[(6-aza-bicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique |
FR2941953A1 (fr) * | 2009-02-10 | 2010-08-13 | Sanofi Aventis | Derives de n-°(2-aza-bicyclo°2.1.1!hex-1-yl)-benzamide, leur preparation et leur application en therapeutique |
FR2941954A1 (fr) * | 2009-02-10 | 2010-08-13 | Sanofi Aventis | Derives de n-°(6-aza-bicyclo°3.2.1!oct-1-yl)-aryl-methyl! benzamide, leur preparation et leur application en therapeutique |
US8563617B2 (en) | 2009-02-16 | 2013-10-22 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8642587B2 (en) | 2009-02-16 | 2014-02-04 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy |
US9096619B2 (en) | 2009-02-16 | 2015-08-04 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9067871B2 (en) | 2009-02-16 | 2015-06-30 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9227930B2 (en) | 2010-08-13 | 2016-01-05 | Abbvie Inc. | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9238619B2 (en) | 2010-08-13 | 2016-01-19 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9045459B2 (en) | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9309200B2 (en) | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8853196B2 (en) | 2011-08-05 | 2014-10-07 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8846741B2 (en) | 2011-11-18 | 2014-09-30 | Abbvie Inc. | N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
WO2014154488A1 (fr) | 2013-03-28 | 2014-10-02 | Syngenta Participations Ag | Procédés de lutte contre des organismes nuisibles résistant aux néonicotinoïdes |
US9586945B2 (en) | 2013-10-17 | 2017-03-07 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9586942B2 (en) | 2013-10-17 | 2017-03-07 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9550754B2 (en) | 2014-09-11 | 2017-01-24 | AbbVie Deutschland GmbH & Co. KG | 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005058317A1 (fr) | Inhibiteurs du transporteur-1 de la glycine | |
WO2005058882A1 (fr) | Composes comprenant des groupes mopholinyle et piperidinyle utilises comme inhibiteurs de glyt1 et de glyt2 | |
WO2005058885A2 (fr) | Composes | |
EP1833811B1 (fr) | Hétérocycles oxygénés en tant que composés inhibiteurs de transporteurs de glycine | |
US20100216837A1 (en) | Glycine transport inhibitors | |
WO2005049023A1 (fr) | Inhibiteurs du transporteur glyt1 | |
EP1838663B1 (fr) | Inhibiteurs du transport de la glycine | |
US20090221577A1 (en) | Compounds having morpholinyl and piperidinyl groups for use as glyt1 inhibitors | |
EP1858869A1 (fr) | Pipéridines acylées en tant qu'inhibiteurs de transporteurs de glycine | |
US20090286828A1 (en) | 2-amino-1-phenylethylcarboxamide derivatives | |
US20090253700A1 (en) | N-'4-4(4-morpholinyl) phenyl!- '(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors | |
EP2041082B1 (fr) | Composés ayant une activité au niveau du transporteur glyt1 | |
US20100016374A1 (en) | Compounds Which Inhibit the Glycine Transporter and Uses Thereof | |
US20090227629A1 (en) | Compounds having activity at the glycine transporter glyt1 and uses thereof | |
WO2007147836A1 (fr) | Composés inhibant le transporteur de la glycine et utilisations en médecine | |
US20090318447A1 (en) | N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1--4-piperidinyl) methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophrenia | |
WO2006094840A1 (fr) | Composés | |
WO2006002956A1 (fr) | Derives de piperidine et utilisation associee en tant qu'inhibiteurs du transporteur de glycine | |
WO2007147839A1 (fr) | Composés inhibant le transporteur de la glycine et utilisations de ceux-ci en médecine | |
WO2007147834A1 (fr) | Composés inhibant le transporteur de la glycine et utilisations de ceux-ci en médecine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |